November 2, 2023:  TBD

May 24, 2023:  Successes & Challenges in the Science of Cell & Gene Therapies

   Mike Cohen, Managing Partner, Osage University Partners

   Tracy Dowling, General Counsel & Head of BD, AskBio

   John Maris, Co-Founder, Hulu Therapeutics & Division of Oncology, CHOP

   Dan Takefman, former Head of Regulatory Affairs, Spark Therapeutics & former Chief of 

Gene Therapy Branch, US FDA

   Moderated by Kendra Rose, SVP & Head of BD & L, OI New Platforms, Cardiovascular & 

  Immunology, Bayer Pharmaceuticals